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doi:10.1016/j.jtcvs.2007.02.019bjective: We sought to induce tissue regeneration within a porous patch for repair
f a myocardial defect.
ethods: A basic fibroblast growth factor–loaded porous bovine pericardium pop-
lated with 5-bromo-2=-deoxyuridine–labeled mesenchymal stem cells was used as
cardiac patch (the basic fibroblast growth factor/mesenchymal stem cell patch) to
epair a defect created in a syngeneic rat model. The blank porous pericardium (the
ontrol patch) and the patch loaded with basic fibroblast growth factor were used as
ontrols. The implanted patches were retrieved at 4 and 12 weeks postoperatively
n  5 per group at each time point).
esults: At retrieval, we found that none of the patches were thinned or dilated.
ndothelialization and remesothelialization were observed on the endocardial and
picardial surfaces of patches in each of the studied groups, respectively. Addition-
lly, newly regenerated muscle fibers, glycosaminoglycans, smooth muscle cells,
nd microvessels were seen in the middle layers of all patches, an indication of
issue regeneration. However, the extents of tissue regeneration in the basic fibro-
last growth factor and basic fibroblast growth factor/mesenchymal stem cell
atches were more pronounced than in those of the control patch. This may be
ttributed to the fact that the densities of neomicrovessels observed in the basic
broblast growth factor and basic fibroblast growth factor/mesenchymal stem cell
atches were significantly greater than in those of the control patch. 5-Bromo-2=-
eoxyuridine–labeled cardiomyocytes, smooth muscle cells, and endothelial cells
ere identified in the basic fibroblast growth factor/mesenchymal stem cells patch,
nd no cardiomyocytes were observed in the control and basic fibroblast growth
actor patches.
onclusion: The results provided evidence of tissue regeneration within a porous
ovine pericardium through a process involving cell recruitment and tissue-specific
ifferentiation.
 
he human heart cannot regenerate significantly because adult cardiomyo-
cytes are terminally differentiated and cannot replicate after injury.1 Re-
cently, the identification of stem cells capable of contributing to tissue
egeneration has raised the possibility that cell therapy could be employed for repair
f damaged myocardium.2 Bone marrow– derived mesenchymal stem cells (MSCs)
etain the ability to differentiate into various types of tissue cells and contribute to
he regeneration of a variety of mesenchymal tissues including bone, cartilage,
uscle, and adipose.3,4 Several studies performed on rodents, pigs, and human
emonstrated that MSCs have the potency to differentiate into a cardiomyocyte
henotype in the heart.5,6
The Journal of Thoracic and Cardiovascular Surgery ● Volume 134, Number 1 65
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CDIn our previous study, an acellular bovine pericardium
ith a porous structure was used to repair a myocardial
efect.7 Smooth muscle cells together with neomuscle fibers
ere clearly identified in the porous acellular patch, an
ndication of tissue regeneration. However, cardiomyocytes
ere not found within the patch, a significant limitation of
his study. Additionally, the amount of neomicrovessels
bserved in the porous acellular patch at retrieval was
ignificantly less than that observed in the native myo-
ardium. Vascularization in extracellular matrices
ECMs) to support the metabolic needs of the engineered
issues is generally a prerequisite for achieving appropri-
te tissue regeneration and function.8 Investigations have
ncorporated angiogenic factors such as basic fibroblast
rowth factor (bFGF) to stimulate angiogenesis in tissue-
ngineering ECMs.9
In the present study, to enhance both vascularization and
issue regeneration, a bFGF-loaded porous bovine pericar-
ium populated with MSCs was used as a cardiac patch to
epair a surgically created myocardial defect in the right
entricle of rats.
aterials and Methods
solation, Culture, and Differentiation of MSCs
one marrow MSCs were isolated from femora and tibia of Lewis
ats as described previously.10 To induce myogenic differentiation,
he DNA-demethylating agent 5-azacytidine (5-aza) was added
n the third day and incubated with MSCs for 24 hours. Subse-
uently, the induced MSCs were labeled in vitro for later identi-
cation by adding 100 g/mL 5-bromo-2=-deoxyuridine (BrdU)-
ontaining media to 50% confluent cultures for 24 hours.11 After
-day induction, the cultured cells were immunohistochemically
tained for cardiac-specific troponin T and BrdU.12 Samples (n 
) were analyzed using a FACScan flow cytometer (Becton Dick-
nson, San Jose, Calif).
orous Acellular Bovine Pericardia (Control Patch)
etails of the methodology used to prepare porous acellular bovine
ericardia were previously reported.13,14 The obtained porous
Abbreviations and Acronyms
5-aza  5-azacytidine
-SMA -smooth muscle actin
bFGF  basic fibroblast growth factor
BrdU  5-bromo-2=-deoxyuridine
ECM  extracellular matrix
EVG  elastic van Gieson
GAG  glycosaminoglycan
H&E  hematoxylin and eosin
MSC mesenchymal stem cell
SEM  scanning electron microscopic
SMC  smooth muscle cellcellular tissues were fixed in a 0.05% genipin (Challenge Bio- M
6 The Journal of Thoracic and Cardiovascular Surgery ● July 2roducts, Taichung, Taiwan) aqueous solution (phosphate-buffered
aline solution, pH 7.4) at 37°C for 3 days. The denaturation
emperature (74.8°C  0.2°C), fixation index (58.4%  4.7%),
ore size (159.8  26.7 m), and porosity (94.9%  1.7%)
f the fixed porous acellular tissues (n  5) were previously
eported.15
In the present study, to facilitate cell infiltration and repopula-
ion, the dense layer on each side of the fixed porous acellular
issues was further sliced off using a cryostat microtome. After
reparation of test samples, the porous acellular tissues (the control
atch) were processed for scanning electron microscopic (SEM)
xaminations to investigate their ultrastructures. The obtained
amples were then sterilized in a graded series of ethanol solutions
or loading bFGF and populating MSCs in vitro and for the
ubsequent animal study.
FGF-loaded Acellular Tissues (bFGF Patch)
he sterilized acellular tissues were freeze-dried under aseptic
onditions and then loaded with bFGF using a method described in
he literature.15 Briefly, solutions of human recombinant bFGF at
ifferent known concentrations buffered with phosphate-buffered
aline solution were sterilized using a 0.22-m filter. Subse-
uently, the aforementioned freeze-dried samples were rehydrated
n the prepared bFGF solutions overnight (the bFGF patch). The
mount of bFGF loaded in the patch was determined by measuring
he difference between the initial and residual amounts of bFGF in
he solution using a sandwich enzyme-linked immunosorbent as-
ay (n  5).
FGF-loaded Acellular Tissues Populated
ith MSCs (bFGF/MSC Patch)
fter the process of 5-aza induction and BrdU labeling (for 2
ays), MSCs were washed, harvested from culture dishes using
.05% trypsin solution, and resuspended to a concentration of 1 
06 cells in 50 L of culture medium containing 1250 ng bFGF.
imilar to preparation for the bFGF patch, this medium was then
sed to rehydrate the freeze-dried acellular tissues at 37°C over-
ight (the bFGF/MSC patch). To investigate cell attachment and
istribution on the bFGF/MSC patch, after 18-hour incubation,
amples were fixed in 10% phosphate-buffered formalin for 2 days
nd subsequently processed for histologic and SEM examinations.
nimal Study
nimal care and use were in compliance with the “Guide for the
are and Use of Laboratory Animals” prepared by the Institute of
aboratory Animal Resources, National Research Council, and
ublished by the National Academy Press, revised 1996. Adult
yngeneic Lewis rats weighing 250 to 275 g were used for the right
entricular wall replacement. The prepared patches (control,
FGF, or bFGF/MSC patches, in a disk shape with a diameter of
mm and a thickness of 1.6 mm) were used to repair a transmural
efect surgically created in the right ventricle of syngeneic rat
earts based on a method reported by Ozawa and colleagues.16
picardial Electrograms
12-lead electrocardiographic system (PC-ECG 1200M, Norav
edical, Kiryat Bialik, Israel) was used to acquire the epicardial
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A
CDlectrograms of the implanted patch and its adjacent rat native
yocardium immediately after implantation and at retrieval.17
chocardiography
ardiac ultrasonography was performed with a commercially
vailable echocardiographic system (SONOS 5500, Agilent Tech-
ologies, Andover, Mass) equipped with a 12-MHz broadband
ector transducer before patch implantation and at retrieval. The
eart was imaged in the 2-dimensional mode in short-axis views at
he midpapillary level of the left ventricle to evaluate contractions
f the patch-implanted myocardium at the right ventricle.18
istologic Examinations
he implanted patches were retrieved at 4 and 12 weeks postop-
ratively (n  5 per group at each time point) and were used for
ross and histologic examinations. The samples used for light
icroscopy were fixed in 10% phosphate-buffered formalin, em-
edded in paraffin, sectioned into a thickness of 5 m, and then
tained with hematoxylin and eosin (H&E). Also, sections of test
amples were stained with Masson’s trichrome or elastic van
ieson (EVG) for the detection of collagen fibrils and muscle
bers or stained with safranin-O to visualize glycosaminoglycans
GAGs). Additional sections were stained with a van Gieson
olution to visualize mesothelial cells.19
Immunohistochemical staining with a monoclonal antibody
gainst BrdU was used to identify the cells populated in the
FGF/MSC patch, revealed by a peroxidase-antiperoxidase tech-
ique.10 Additionally, sections of the retrieved patches were
tained with a monoclonal antibody against -sacromeric actin
clone 5C5, Serotec, Kidlington, Oxford, UK).5
A monoclonal antibody against -smooth muscle actin (-
MA, DAKO Corp., Carpinteria, Calif) was used to identify
mooth muscle cells (SMCs). Additional sections were stained for
actor VIII with an immunohistologic technique with a monoclonal
nti-factor VIII antibody (DAKO).20 The density of neomicroves-
els in each studied sample was quantified with a computer-based
mage analysis system (Image-Pro Plus, Media Cybernetics, Silver
pring, Md) and converted to vessels/mm2. Five different micro-
copic fields (100 by ECLIPSE-E800, Nikon, Tokyo, Japan) of
ach patch portion of the right ventricular wall were randomly
elected.10
tatistical Analysis
tatistical analysis for the determination of differences in the
easured properties between groups was accomplished using
-way analysis of variance and determination of confidence inter-
als, which was performed with a computer statistical program
Statistical Analysis System, Version 6.08, SAS Institute Inc.,
ary, NC). All data are presented as mean values  standard
eviations.
esults
henotype of MSCs Before Implantation
orphology of the isolated cells initially appeared small
nd rounded with a tendency to grow in clusters. Nonad-
erent cells were removed by medium change at 24 hours
nd every 4 days thereafter. Elongated cells with a spindle- t
The Journal of Thorachaped morphology appeared after 72 hours and reached
onfluence after 10 to 14 days. Seven days after 5-aza
reatment, flow cytometric analysis of the 5-aza-induced
SCs demonstrated a significant difference in the expres-
ion of troponin T as compared with the control group
Figure E1). The nuclei of the cells induced by 5-aza were
abeled with BrdU for 24 hours pretransplantation. It was
ound that 97.6%  1.2% of the culture cells stained pos-
tively (n  5).
est Patches
fter fixation by genipin, the color of acellular bovine
issues turned into bluish. A dense layer was present on each
ide of the acellular bovine pericardia (Figure 1, a). After
licing off these dense layers with a cryostat microtome, a
orous structure beneath was revealed (the control patch,
igure 1, b and d ). It was found that the highest amount of
FGF that could be loaded in porous acellular bovine peri-
ardia was approximately 500  15 ng per sample (a 5-mm
isk with a thickness of 1.6 mm, n  5). This specific patch
the bFGF patch) was used for the animal study. Results of
he in vitro study revealed that after an initial burst, bFGF
as released gradually in a sustained manner. After cell
opulating, MSCs were mostly present in the surface layers
f porous acellular tissues and had a uniform, viable spindle-
haped morphology (18 hours after cell seeding, the bFGF/
SC patch contained the same amount of bFGF as in the
FGF patch; Figure 1, c and e). BrdU incorporation was
vident in 90% of the populated MSCs (Figure 1, f ).
picardial Electrograms
mmediately after implantation, no epicardial electrogram
ignals were observed in the studied groups. At 4 weeks
ostoperatively, the mapping of the electrograms on each of
he studied group showed low amplitudes as compared with
hat observed on its adjacent native myocardium. The am-
litudes of local electrograms on the epicardial surfaces of
ll studied groups increased significantly with increasing the
mplantation duration. However, the amplitudes of the elec-
rograms observed on the bFGF and bFGF/MSC patches
ere significantly stronger than those on the control patch
hroughout the entire course of the study.
chocardiography
hort-axis 2-dimensional images of the normal heart as well
s the control patch–implanted heart, the bFGF patch–
mplanted heart, and the bFGF/MSC patch–implanted heart
t retrieval were obtained using a commercially available
chocardiographic system. The results indicated that all
tudied groups were akinetic. The differences in the global
ontractions at the right ventricles for all patch-implanted
earts were difficult to differentiate when compared with
he normal heart.
ic and Cardiovascular Surgery ● Volume 134, Number 1 67
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CDross Examination
n the inner (endocardial) surface, intimal thickening was
bserved for all studied groups; however, no thrombus
ormation was found (Figure E2). No apparent tissue adhe-
ion was observed on the outer (epicardial) surface of any of
he patches throughout the entire course of the study. Ad-
itionally, no aneurysmal dilation was seen in any of the
tudied groups.
istologic Findings
t 4 weeks postoperatively, host cells together with neo-
onnective tissue fibrils and neomicrovessels were clearly
bserved to fill the pores within the inner and outer layers of
atches from all studied groups, an indication of tissue
egeneration (Figure E3). The neoconnective tissue fibrils (
8 The Journal of Thoracic and Cardiovascular Surgery ● July 2egenerated in the bFGF and bFGF/MSC patches were more
ompact and organized than control patch samples. Factor
III–positive endothelial cells were visible on the inner
urfaces of patches from all studied groups, and mesothelial
ells, positively stained with van Gieson, were observed on
heir outer surfaces (Figure 2).
Tissue regeneration was also observed to fill most of the
ores in the middle layers of the bFGF and bFGF/MSC
atches, although there were still some unfilled pores
resent in the control patch. The neoconnective tissue fibrils
egenerated in these studied patches were identified to be
eomuscle fibers (stained red) with some neocollagen fibrils
stained blue), as determined with Masson’s trichrome stain
Figure 1. Ultrastructures of a porous
acellular bovine pericardium (a) before
and (b) after slicing off the dense lay-
ers on its surfaces using a cryostat
microtome; (c) SEM micrograph of the
bFGF/MSC patch, 18 hours after cell
seeding; (d) photomicrograph of a po-
rous acellular bovine pericardium (the
control patch) before implantation stained
with H&E; (e) photomicrograph of the
bFGF/MSC patch before implantation
stained with H&E; (f) photomicrograph
of the bFGF/MSC patch stained with a
monoclonal antibody against BrdU.
Scale bars, 100 m (d) and 50 m (e
and f).Figure 3). The identified neomuscle fibers were further
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A
CDonfirmed by the EVG stain. Additionally, there were some
AGs regenerated within the pores of each studied patch.
oreover, -SMA positively stained cells were seen in
atches from all studied groups (Figure 3), indicating the
resence of SMCs.
The densities of neomicrovessels found in the bFGF
462 29 vessels/mm2) and bFGF/MSC patches (489 36
essels/mm2) were significantly greater than that observed
n the control patch (189  37 vessels/mm2), and that in the
ormal/adjacent myocardium was about 1161  75 vessels/
m2. Additionally, BrdU-labeled cells were clearly identi-
ed in the bFGF/MSC patch (Figure E4). Some of the
dentified BrdU-labeled cells were further stained positively
or -sacromeric actin, indicating that a portion of the
mplanted MSCs had been differentiated toward the car- o
The Journal of Thoraciomyogenic lineage and expressed cytoplasmic -sacromeric
ctin. Moreover, a few capillary walls composed of BrdU-
abeled endothelial cells and some BrdU-labeled SMCs
ere recognized in the bFGF/MSC patch. The BrdU-
abeled cardiomyocytes, SMCs, and endothelial cells ob-
erved in the bFGF/MSC patch were about 32  3, 74  5,
nd 17  3 cells/mm2, respectively. In contrast, no cardio-
yocytes were observed in the control and bFGF patches.
At 12 weeks postoperatively (Figure 4), the neoconnec-
ive tissue fibrils seen in all studied groups were compara-
ively more compact and organized than their counterparts
bserved at 4 weeks postoperatively. The density of neomi-
rovessels observed in the control patch (187  23 vessels/
m2) did not significantly increase with time, whereas those
Figure 2. Photomicrographs of the in-
ner (endocardial) and outer (epicar-
dial) surfaces of the control, bFGF, and
bFGF/MSC patches retrieved at 4 weeks
postoperatively stained for factor VIII
and with van Gieson, respectively.
Scale bars, 30 m.bserved in the bFGF (524  18 vessels/mm2) and bFGF/
ic and Cardiovascular Surgery ● Volume 134, Number 1 69
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7
A
CDSC (552  25 vessels/mm2) patches relatively increased.
he amounts of the BrdU-labeled cardiomyocytes (35  4
ells/mm2), SMCs (79 6 cells/mm2), and endothelial cells
25  4 cells/mm2) stayed approximately the same as those
bserved at 4 weeks postoperatively. There were still no
ardiomyocytes seen in the control and bFGF patches.
iscussion
ecently, bone marrow–derived MSCs have gained atten-
ion for their therapeutic potential. Under differentiation-
nducing culture conditions, MSCs have the capacity to
ifferentiate into other cell types.3 During myogenic differ-
ntiation, MSCs continued to proliferate and readily formed
yotubes. Additionally, the results obtained in the flow t
0 The Journal of Thoracic and Cardiovascular Surgery ● July 2ytometric analysis showed that the induced MSCs stained
ositively for cardiac-specific troponin T.
At retrieval, it was found that none of the patches thinned
r dilated throughout the entire course of the study. This
ndicated that the mechanical strength of each of the studied
roups was strong enough to tolerate the right ventricular
ressure of the animal and prevented the implanted patch
rom dilation.
Host cells together with neoconnective tissue fibrils and
eomicrovessels were clearly observed in the outer (epicar-
ial) layers of the control, bFGF, and bFGF/MSC patches,
ndicating that the outer layers of all studied groups became
ell integrated with their host tissues (Figure E3). Addi-
Figure 3. Photomicrographs of the
middle layers of the control, bFGF,
and bFGF/MSC patches retrieved at 4
weeks postoperatively stained with
Masson’s trichrome and for -SMA,
respectively. The positive stained cells
for -SMA is indicated by. Scale bars,
50 m.ionally, an intact layer of neomesothelial cells, resting on
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A
CDhe regenerated tissues, was identified by the van Gieson
tain (Figure 2). Several authors have suggested that mul-
ipotential cells present within the connective matrix can
ifferentiate into mesothelial cells and contribute to surface
eepithelialization.21 Remesothelialization on the outer sur-
ace of each implanted patch is assumed to play an impor-
ant role in the prevention of postsurgical adhesions (Figure
2). Whitaker and associates22 have documented that me-
othelial cells prevent adhesions. It is known that the epi-
ardium forms the outer covering of the heart and has an
xternal layer of flat mesothelial cells.23
An intimal thickening covered with endothelial cells was
ound on the inner (endocardial) surfaces of patches from all
tudied groups. This finding suggested that host endocardial
ndothelial cells or endothelial progenitor cells were in-
olved in the endothelialization of the inner surface of each
mplanted patch and prevented it from thrombus formation
Figure E2).24 Endothelialization is one of the most prom-
sing mechanisms to reduce thrombogenicity of any cardio-
ascular implants.25
Regenerated muscle fibers (with some collagen fibrils),
AGs, and microvessels were observed in the middle layers
f patches of all studied groups (Figure 3). The extent of
issue regeneration in the bFGF and bFGF/MSC patches
as more pronounced than that in the control patch through-
ut the entire course of the study. This may be attributed to
he fact that the densities of neomicrovessels observed in the
FGF and bFGF/MSC patches were significantly greater
han that seen in the control patch. p
The Journal of ThoracDelivery of potent angiogenic factors, such as bFGF,
rom the implanted ECMs may allow vascularization to be
nhanced.9 It is known that site-specific delivery of angio-
enic molecules may provide an efficient means of stimu-
ating localized vessel formation. Our previous results
howed that the GAGs inherent in acellular biologic tissues
an be used for the binding, modulation, and sustained
elease of biologically active bFGF.26 The binding of bFGF
ith GAGs is mediated by specific ionic interactions be-
ween both 2-O-sulfate groups and N-sulfate groups of
AG molecules and certain lysine and arginine residues on
FGF.27 The densities of neomicrovessels observed in the
FGF and bFGF/MSC patches increased relatively with
ime. This result suggested that the sustained release of
FGF from both patches continued to be effective in en-
ancing vascularization and in the generation of new
issues.
-SMA positively stained cells were identified in all
tudied groups (Figure 3), indicating the presence of SMCs.
t is known that SMCs permit formation of a muscular tissue
Figure 3, stained red by Massson’s trichrome) in addition
o collagen formation (stained blue by Massson’s trichrome). 28
hese findings suggested that host progenitor cells from the
ystemic circulation or the surrounding tissue may be rele-
ant to the presence of SMCs in the implanted patches.
revious studies reported that SMC transplantation into
yocardial infarct scar tissues improves heart function and
Figure 4. Photomicrographs of the mid-
dle layer ¡ of the bFGF/MSC patch re-
trieved at 12 weeks postoperatively (a)
stained with H&E; (b and c) the insets 1
and 2 of (a) showed the additional stain-
ing with Safranin-O or for factor VIII; (d)
stained with Masson’s trichrome; (e, f,
and g) the insets 1, 2, and 3 of (d) showed
the additional staining with EVG for
-SMA and double-immunostaining for
-sacromeric actin (blue) and anti-BrdU
(brown); (h) the negative data for the
bFGF patch retrieved at 12 weeks post-
operatively. Scale bars, 50 m (a and b),
30m (b, c, e, and f), and 10m (g and h).revents ventricle dilatation.29
ic and Cardiovascular Surgery ● Volume 134, Number 1 71
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7
A
CDThe amplitudes of epicardial electrograms observed on
he bFGF and bFGF/MSC patches were stronger than that
een on the control patch during the entire course of the
tudy, an indication of a better electrical conductance. This
ay be possibly due to a more pronounced tissue regener-
tion observed in the 2 former patches. However, we were
ot able to discern the local electrograms observed on the
mplanted patches from the hosts’ own heart electrical
ctivity.
Despite clear evidences of tissue regeneration, no cardi-
myocytes were observed in the control and bFGF patches
uring the study. It is known that adult cardiomyocytes have
ssentially no regenerative capacity.5 In contrast, a number
f cardiomyocytes, which stained positively for BrdU and
-sacromeric actin, were observed in the bFGF/MSC patch
t 4 weeks postoperatively (Figure E3). It was reported that
he MSCs transplanted into a myocardium environment can
xpress myogenic-specific proteins such as -sacromeric
ctin.10 This result indicated that the induced MSCs, trans-
erred within the patch, can engraft and differentiate into
ardiomyocytes.
The amount of cardiomyocytes observed in the bFGF/
SC patch at 12 weeks postoperatively was comparable to
hat seen at 4 weeks postoperatively. This implied that the
ardiomyocytes differentiated from MSCs survived through-
ut the entire course of the study. It was reported that
ascularization, induced mainly by the loaded bFGF in the
resent study as described above, is important for the long-
erm survival of the transplanted cells.10 It is known that
xygen supply is often limited in a tissue-engineering ECM.
ells more than approximately 200 m from a blood vessel
uffer from hypoxia and die.30 In tissue repair or regenera-
ion, the vasculature of the host penetrates macroporous
atrices utilized for cell delivery via the process of
ascularization.
The echocardiographic results showed that the bFGF/
SC patch was akinetic, despite the presence of cardiomy-
cytes. This may be attributed to the fact that there were not
nough cardiomyocytes present in the bFGF/MSC patch. In
ur in vitro study, it was found that after BrdU labeling, the
roliferation of MSCs were significantly slowed. Addition-
lly, there was no evidence that the implanted MSCs en-
aged into functional bonds with host cardiomyocytes,
hich were functional and contractile. These facts are the
rimary limitations of the present study.
onclusions
he study proposed utilization of a bFGF-loaded porous
cellular bovine pericardium populated with MSCs as a
atch to repair a myocardial defect. Vascularization together
ith cardiomyocytes differentiated from MSCs and neo-
uscle fibers were clearly observed in the patch, an indi-ation of tissue regeneration. These observations indicated
2 The Journal of Thoracic and Cardiovascular Surgery ● July 2hat the developed patch improved the limited efficacy
f currently available cardiac patches in the long-term
esults.
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CDFigure E1. Representative results from 5 independently performed experiments of flow cytometric analysis of
(a) 5-aza-induced MSCs and (b) BrdU-labeled MSCs.3.e1 The Journal of Thoracic and Cardiovascular Surgery ● July 2007
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A
CDFigure E2. Photographs of the inner (endocardial) and outer (epicardial) surfaces of the control, bFGF, and
bFGF/MSC patches retrieved at 12 weeks postoperatively. The implanted patch is indicated by arrow. ¡The Journal of Thoracic and Cardiovascular Surgery ● Volume 134, Number 1 73.e2
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A
CDFigure E3. Photomicrographs of the inner (endocardial) and outer (epicardial) layers of the control, bFGF, and
bFGF/MSC patches retrieved at 4 weeks postoperatively stained with H&E; insets of the bFGF/MSC patch magnified
an additional fourfold photomicrographs that stained for factor VIII. Scale bars, 100 m.3.e3 The Journal of Thoracic and Cardiovascular Surgery ● July 2007
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A
CDFigure E4. Photomicrographs of the bFGF/MSC patch retrieved at 4 weeks postoperatively double-immunostained
for: (a) -sacromeric actin (blue) and anti-BrdU (brown); (b) -SMA (blue) and anti-BrdU (brown); (c) factor VIII
(blue) and anti-BrdU (brown). Scale bars, 10 m.The Journal of Thoracic and Cardiovascular Surgery ● Volume 134, Number 1 73.e4
